PWPS
DNLI icon

Pinnacle Wealth Planning Services’s Denali Therapeutics DNLI Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$298K Buy
11,587
+181
+2% +$3.72K 0.03% 374
2026
Q1 		$219K Buy
11,406
+8,449
+286% +$168K 0.02% 447
2025
Q4 		$48.8K Buy
+2,957
New +$49.9K 0.01% 1211
2021
Q1 		– Sell
-332
Closed -$28K – 781
2020
Q4 		$28K Buy
+332
New +$20.1K 0.01% 1016

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Wealth Planning Services's DNLI Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its Denali Therapeutics (DNLI) stake by 1.6% in Q2 2026, buying an estimated $3.72K and bringing the position to 11,587 shares worth $298K. The position accounts for 0.03% of the portfolio, ranked #374.

Pinnacle Wealth Planning Services first reported a position in DNLI in Q4 2020 and has held it in 4 quarters since. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Pinnacle Wealth Planning Services held 11,587 shares of Denali Therapeutics worth $298K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 181 Denali Therapeutics shares in Q2 2026, an estimated $3.72K.
  • Denali Therapeutics made up 0.03% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #374 holding.
  • Pinnacle Wealth Planning Services first reported a position in Denali Therapeutics in Q4 2020 and has held it in 4 quarters since.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.